Literature DB >> 18807147

How to handle low-molecular-weight heparins in patients with decreased renal function: an open issue.

Giuseppe Stefano Netti1, Maurizio Margaglione, Loreto Gesualdo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18807147     DOI： 10.1007/s11739-008-0195-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  19 in total

Review 1.  Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.

Authors:  J Hirsh; S S Anand; J L Halperin; V Fuster
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

Review 2.  Low-molecular-weight heparins: are they all the same?

Authors:  Richard H White; Jeffrey S Ginsberg
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

Review 3.  Low-molecular-weight heparins.

Authors:  J I Weitz
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

Review 4.  Is impaired renal function a contraindication to the use of low-molecular-weight heparin?

Authors:  Jeff Nagge; Mark Crowther; Jack Hirsh
Journal:  Arch Intern Med       Date:  2002 Dec 9-23

5.  Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency.

Authors:  Wendy Lim; Francesco Dentali; John W Eikelboom; Mark A Crowther
Journal:  Ann Intern Med       Date:  2006-05-02       Impact factor: 25.391

Review 6.  Low-molecular-weight heparin in patients with chronic renal insufficiency.

Authors:  Wendy Lim
Journal:  Intern Emerg Med       Date:  2008-06-18       Impact factor: 3.397

7.  Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Hirsh; Robert Raschke
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin.

Authors:  Natalya Thorevska; Yaw Amoateng-Adjepong; Ramin Sabahi; Irina Schiopescu; Anan Salloum; Visvanathan Muralidharan; Constantine A Manthous
Journal:  Chest       Date:  2004-03       Impact factor: 9.410

9.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

Authors:  T E Warkentin; M N Levine; J Hirsh; P Horsewood; R S Roberts; M Gent; J G Kelton
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

10.  Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin.

Authors:  Sheryl L Chow; Kimberly Zammit; Kathleen West; MaryAnne Dannenhoffer; Angel Lopez-Candales
Journal:  J Clin Pharmacol       Date:  2003-06       Impact factor: 3.126
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.